FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2323423445> ?p ?o ?g. }

• W2323423445 endingPage "87" @default.
• W2323423445 startingPage "78" @default.
• W2323423445 abstract "Psychostimulants are first-line therapy for patients with attention-deficit/hyperactivity disorder (ADHD). However, some patients are not optimal responders to monotherapy or present as comorbid for a variety of other disorders that either preclude the use of stimulants or produce a symptom complex that is resistant to monotherapy. Unfortunately, there are few agents well studied in combination with psychostimulants for patients with ADHD. The combination of psychostimulants with alpha2-adrenergic agonists may offer a complementary approach to treating such complex patients. The rationale for combination therapy is that the primary effects of stimulants and alpha2-adrenergic agonists are mediated by different but complementary mechanisms of action, emphasizing different neurotransmitter systems, which together modulate prefrontal cortex functioning. Although immediate-release clonidine and guanfacine have long been studied in ADHD, their usage has been limited by rapid absorption and clearance, negative side effects, and reduced efficacy compared with stimulants. New controlled-release formulations of the alpha2-adrenergic agonists have overcome some of these limitations, with recent clinical trials demonstrating their enhanced tolerability and effectiveness for treatment of ADHD in children and adolescents. Studies with each of these new formulations (ie, guanfacine extended release and clonidine hydrochloride extended-release tablets) in combination with psychostimulants have demonstrated that the addition of an alpha2-adrenergic agonist to psychostimulant therapy significantly enhances efficacy without compromising safety. This review will encompass the clinical study database for novel formulations of alpha2-adrenergic agonists, enabling the reader to appreciate their place in ADHD treatment as well as the potential utility of a combination approach with psychostimulants for patients with complex ADHD." @default.
• W2323423445 created "2016-06-24" @default.
• W2323423445 creator A5024486752 @default.
• W2323423445 date "2010-09-01" @default.
• W2323423445 modified "2023-09-30" @default.
• W2323423445 title "The Role of Alpha₂-Adrenergic Agonists in Attention-Deficit/Hyperactivity Disorder" @default.
• W2323423445 cites W1555966144 @default.
• W2323423445 cites W181776045 @default.
• W2323423445 cites W1965229373 @default.
• W2323423445 cites W1967694983 @default.
• W2323423445 cites W1972551153 @default.
• W2323423445 cites W1973930439 @default.
• W2323423445 cites W1976881402 @default.
• W2323423445 cites W1978822116 @default.
• W2323423445 cites W1981089515 @default.
• W2323423445 cites W1982166376 @default.
• W2323423445 cites W1991162436 @default.
• W2323423445 cites W2002134787 @default.
• W2323423445 cites W2009486192 @default.
• W2323423445 cites W2011621982 @default.
• W2323423445 cites W2013810982 @default.
• W2323423445 cites W2015372371 @default.
• W2323423445 cites W2017232520 @default.
• W2323423445 cites W2018897037 @default.
• W2323423445 cites W2020085742 @default.
• W2323423445 cites W2022741651 @default.
• W2323423445 cites W2023325653 @default.
• W2323423445 cites W2023946047 @default.
• W2323423445 cites W2028405262 @default.
• W2323423445 cites W2030647917 @default.
• W2323423445 cites W2036228531 @default.
• W2323423445 cites W2038912289 @default.
• W2323423445 cites W2041413905 @default.
• W2323423445 cites W2042348492 @default.
• W2323423445 cites W2046835548 @default.
• W2323423445 cites W2064910801 @default.
• W2323423445 cites W2065679464 @default.
• W2323423445 cites W2067292897 @default.
• W2323423445 cites W2069181034 @default.
• W2323423445 cites W2071249450 @default.
• W2323423445 cites W2075473160 @default.
• W2323423445 cites W2077465062 @default.
• W2323423445 cites W2077614189 @default.
• W2323423445 cites W2082765847 @default.
• W2323423445 cites W2088839547 @default.
• W2323423445 cites W2089277926 @default.
• W2323423445 cites W2093129906 @default.
• W2323423445 cites W2095388594 @default.
• W2323423445 cites W2097094466 @default.
• W2323423445 cites W2108379938 @default.
• W2323423445 cites W2109935740 @default.
• W2323423445 cites W2113181557 @default.
• W2323423445 cites W2114290463 @default.
• W2323423445 cites W2115095583 @default.
• W2323423445 cites W2116414711 @default.
• W2323423445 cites W2120183527 @default.
• W2323423445 cites W2120286754 @default.
• W2323423445 cites W2122694895 @default.
• W2323423445 cites W2123414152 @default.
• W2323423445 cites W2124264649 @default.
• W2323423445 cites W2134421313 @default.
• W2323423445 cites W2137263250 @default.
• W2323423445 cites W2143954917 @default.
• W2323423445 cites W2146601572 @default.
• W2323423445 cites W2148819542 @default.
• W2323423445 cites W2151488696 @default.
• W2323423445 cites W2159875740 @default.
• W2323423445 cites W2399638631 @default.
• W2323423445 cites W2601578636 @default.
• W2323423445 cites W4240979396 @default.
• W2323423445 cites W4255396331 @default.
• W2323423445 doi "https://doi.org/10.3810/pgm.2010.09.2204" @default.
• W2323423445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20861591" @default.
• W2323423445 hasPublicationYear "2010" @default.
• W2323423445 type Work @default.
• W2323423445 sameAs 2323423445 @default.
• W2323423445 citedByCount "33" @default.
• W2323423445 countsByYear W23234234452012 @default.
• W2323423445 countsByYear W23234234452013 @default.
• W2323423445 countsByYear W23234234452014 @default.
• W2323423445 countsByYear W23234234452015 @default.
• W2323423445 countsByYear W23234234452016 @default.
• W2323423445 countsByYear W23234234452018 @default.
• W2323423445 countsByYear W23234234452019 @default.
• W2323423445 countsByYear W23234234452020 @default.
• W2323423445 countsByYear W23234234452023 @default.
• W2323423445 crossrefType "journal-article" @default.
• W2323423445 hasAuthorship W2323423445A5024486752 @default.
• W2323423445 hasConcept C118552586 @default.
• W2323423445 hasConcept C126322002 @default.
• W2323423445 hasConcept C158453852 @default.
• W2323423445 hasConcept C170493617 @default.
• W2323423445 hasConcept C197934379 @default.
• W2323423445 hasConcept C2777112843 @default.
• W2323423445 hasConcept C2778375690 @default.
• W2323423445 hasConcept C2778399450 @default.
• W2323423445 hasConcept C2778781522 @default.
• W2323423445 hasConcept C2778938600 @default.

• next